From: Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience
Variables | Number (%) |
---|---|
Age, median years (range) | 46.5 (23–80) |
Gender | |
Male | 59 (82%) |
Female | 13 (18%) |
Smoker | |
Yes | 30 (41.5%) |
No | 40 (55.5%) |
Unknown | 2 (3%) |
AJCC stage | |
I | 3 (4%) |
II a/b | 7/16 (total 32%) |
III | 19 (26%) |
IV a/b/c | 6/14/7 (total 37.5%) |
T stage | |
T1 | 30 (41.5%) |
T2 | 11 (15%) |
T2a | 2 (3%) |
T2b | 6 (8%) |
T3 | 15 (21%) |
T4 | 8 (11%) |
N stage | |
N0 | 13 (18%) |
N1 | 24 (33%) |
N2 | 20 (28%) |
N3 | 15 (21%) |
Combination with chemotherapy | |
Yes | 45 (62.5%) |
No | 27 (37.5%) |
Brachytherapy | |
Yes | 15 (21%) |
Stage I: 1 patients | |
Stage IIa 3 patients | |
Stage IIb 7 patients | |
Stage III 4 patients | |
No | 57 (79%) |
PET/CT fusion | |
Yes | 67 (93%) |
No | 5 (7%) |